Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis

Clinical Genetics

Volumn 74, Issue 4, 2008, Pages 358-366

  Boyd, C ^a   Smith, M J ^a   Kluwe, L ^b   Balogh, A ^a   Maccollin, M ^a   Plotkin, Scott R ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

INI1; Neurofibromatosis; Schwannoma; Schwannomatosis; SMARCB1; Tumor suppressor gene

Indexed keywords

GENOMIC DNA; NEUROFIBROMATOSIS TYPE 2 PROTEIN; PROTEIN SMARCB1; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SPLICING; EXON; FAMILIAL DISEASE; GENE AMPLIFICATION; GENE DELETION; GENE DUPLICATION; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; INTRON; MICROSATELLITE MARKER; MISSENSE MUTATION; NEURILEMOMA; NEUROFIBROMATOSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCHWANNOMATOSIS; TUMOR SUPPRESSOR GENE;

CHROMOSOMAL PROTEINS, NON-HISTONE; COHORT STUDIES; DNA-BINDING PROTEINS; FAMILY; GENE DOSAGE; GENES, NEUROFIBROMATOSIS 2; GENES, TUMOR SUPPRESSOR; HUMANS; MICROSATELLITE REPEATS; NEURILEMMOMA; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTORS;

EID: 52449103743     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2008.01060.x     Document Type: Article

References (38)

1. MacCollin M, Chiocca EA, Evans DG et al. Diagnostic criteria for schwannomatosis. Neurology 2005: 64: 1838-1845.
2. MacCollin M, Willett C, Heinrich B et al. Familial schwannomatosis: exclusion of the NF2 locus as the germline event. Neurology 2005: 60: 1968-1974.
3. Kaufman DL, Heinrich BS, Willett C et al. Somatic instability of the NF2 gene in schwannomatosis. Arch Neurol 2003: 60: 1317-1320.
4. Leverkus M, Kluwe L, Roll EM et al. Multiple unilateral schwannomas: segmental neurofibromatosis type 2 or schwannomatosis? Br J Dermatol 2003: 148: 804-809.
5. Kalpana GV, Marmon S, Wang W, Crabtree GR, Goff S. Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science 2003: 266: 2002-2006.
6. Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 1999: 59: 74-79.
7. Sevenet N, Lellouch-Tubiana A, Schofield D et al. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum Mol Genet 1999: 13: 2359-2368.
8. Bruder CE, Dumanski JP, Kedra D. The mouse ortholog of the human SMARCB1 gene encodes two splice forms. Biochem Biophys Res Commun 1999: 257: 886-890.
9. Weber M, Stockhammer F, Schmitz U, von Deimling A. Mutational analysis of INI1 in sporadic human brain tumors. Acta Neuropathol 2001: 101: 479-482.
10. Hulsebos TJ, Plomp AS, Wolterman RA, Robanus-Maandag EC, Baas F, Wesseling P. Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet 2007: 80: 805-810.
11. Sestini R, Bacci C, Provenzano A, Genuardi M, Papi L. Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas. Hum Mutat 2008: 29: 227-231.
12. Hadfield K, Newman W, Bowers N et al. Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis. J Med Genet 2008: 45: 332-339.
13. Anderson MA, Gusella JF. Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines. In Vitro 1984: 20: 856-858.
14. Garvin AJ, Re GG, Tarnowski BI, Hazen-Martin DJ, Sens DA. The G401 cell line, utilized for studies of chromosomal changes in Wilms'tumor, is derived from a rhabdoid tumor of the kidney. Am J Pathol 1993: 142: 375-380.
15. Favre M, Butticaz C, Stevenson B, Jongeneel CV, Telenti A. High frequency of alternative splicing of human genes participating in the HIV-1 life cycle. J Acquir Immune Defic Syndr 2003: 34: 127-133.
16. Mimori K, Inoue H, Shiraishi T et al. A single-nucleotide polymorphism of SMARCB1 in human breast cancers. Genomics 2002: 80: 254-258.
17. Aghi M, Kluwe L, Webster MT et al. Unilateral vestibular schwannoma with other neurofibromatosis type 2-related tumors: Clinical and molecular study of a unique phenotype. J Neurosurg 2006: 104: 201-207.
18. Buratti E, Baralle M, Baralle FE. Defective splicing, disease and therapy: Searching for master checkpoints in exon definition. Nucleic Acids Res 2006: 34: 3494-3510.
19. Patil S, Perry A, MacCollin M et al. Immunohistochemical analysis supports a role for INI1/SMARCB1 in hereditary forms of schwannomas, but not in solitary, sporadic schwannomas. Brain Pathol 2008: (in press).
20. Jacoby LB, Jones D, Davis K et al. Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis. Am J Hum Genet 1997: 61: 1293-1302.
21. Kluwe L, Mautner V, Heinrich B, Dezube R, Jacoby LB, MacCollin M. Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas. J Med Genet 2003: 40: 109-114.
22. Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/ rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 2002: 8: 3461-3467.
23. Fujisawa H, Takabatake Y, Fukusato T, Tachibana O, Tsuchiya Y, Yamashita J. Molecular analysis of the rhabdoid predisposition syndrome in a child: A novel germline hSNF5/INI1 mutation and absence of c-myc amplification. J Neurooncol 2003: 63 (3): 257-262.
24. Bourdeaut F, Freneaux P, Thuille B et al. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities. J Pathol 2007: 211: 323-330.
25. Fujita M, Sato M, Nakamura M et al. Multicentric atypical teratoid/ rhabdoid tumors occurring in the eye and fourth ventricle of an infant: case report. J Neurosurg 2005: 102 (3Suppl): 299-302.
26. Savla J, Chen TT, Schneider NR, Timmons CF, Delattre O, Tomlinson GE. Mutations of the hSNF5/INI1 gene in renal rhabdoid tumors with second primary brain tumors. J Natl Cancer Inst 2000: 92: 648-650.
27. Sevenet N, Sheridan E, Amram D, Schneider P, Handgretinger R, Delattre O. Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet 1999: 65: 1342-1348.
28. Fujisawa H, Misaki K, Takabatake Y, Hasegawa M, Yamashita J. Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation. J Neurooncol 2005: 73: 117-124.
29. Janson K, Nedzi LA, David O et al. Predisposition to atypical teratoid/ rhabdoid tumor due to an inherited INI1 mutation. Pediatr Blood Cancer 2006: 47: 279-284.
30. Lee HY, Yoon CS, Sevenet N, Rajalingam V, Delattre O, Walford NQ. Rhabdoid tumor of the kidney is a component of the rhabdoid predisposition syndrome. Pediatr Dev Pathol 2002: 5: 395-399.
31. Ammerlaan AC, Ararou A, Houben MP et al. Long-term survival and transmission of INI1-mutation via nonpenetrant males in a family with rhabdoid tumour predisposition syndrome. Br J Cancer 2008: 98: 474-479.
32. Biegel JA, Fogelgren B, Wainwright LM, Zhou JY, Bevan H, Rorke LB. Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor. Genes Chromosomes Cancer 2000: 28: 31-37.
33. Giunti L, Bernini G, Forni M, Tucci F, Wheeler E, Sardi I. Clonality analysis of pediatric multiple tumors: Two case reports and laboratory investigation. J Pediatr Hematol Oncol 2006: 28: 241-248.
34. Taylor MD, Gokgoz N, Andrulis IL, Mainprize TG, Drake JM, Rutka JT. Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene. Am J Hum Genet 2000: 66: 1403-1406.
35. Vogel KS, Klesse LJ, Velasco-Miguel S, Meyers K, Rushing EJ, Parada LF. Mouse tumor model for neurofibromatosis type 1. Science 1999: 286: 2176-2179.
36. Cichowski K, Shih TS, Schmitt E et al. Mouse models of tumor development in neurofibromatosis type 1. Science 1999: 286: 2172-2176.
37. Schmitz U, Mueller W, Weber M, Sevenet N, Delattre O, von Deimling A. INI1 mutations in meningiomas at a potential hotspot in exon 9. Br J Cancer 2001: 84: 199-201.
38. Rieske P, Zakrzewska M, Piaskowski S et al. Molecular heterogeneity of meningioma with INI1 mutation. Mol Pathol 2003: 56: 299-301.